Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Androcur TM

Active ingredients: cyproterone

What it is used for

WOMEN: Moderately severe to severe signs of androgenization. Moderately severe/severe forms of hirsutism.moderately severe/severe androgen-dependent loss of scalp hair (moderately severe/severe androgenic alopecia). Moderately severe/severe forms of acne and/or seborrhoea associated with other features of androgenization.Cyproterone acetate inhibits the influence of male sex hormones which are also produced by the female. It is thus possible to treat diseases in women caused either by increased production of androgens or a particular sensitivity to these hormones. Hirsutism and alopecia may be expected to recur over a period of time after cessation of treatment.If Androcur is taken during pregnancy, the properties of the preparation may lead to signs of feminisation in the male foetus. Therefore, in women of childbearing potential, pregnancy must be excluded at the commencement of treatment and ethinyloestradiol taken as well to ensure contraception. This also promotes regular menstruation.MEN:Reduction of drive in sexual deviations Androcur reduces the force of the sexual urge in men with sexual deviations. Whilst under treatment the man can control himself better in a predisposing stimulatory situation, but there is no influence on any deviating direction of sexual drive. Abnormal patterns of sexual behaviour require treatment when they are distressing to the patient. A pre-requisite for therapy is the desire by the patient for treatment.Androcur therapy should be supplemented by psychotherapeutic and sociotherapeutic measures in order to exploit the period of reduced drive for personal and social re-orientation.Inoperable prostatic carcinoma to suppress "flare" with initial LHRH analogue therapy in long term palliative treatment where LHRH analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred in the treatment of hot flushes in patients treated with LHRH analogues or who have had orchidectomy.

How to take it

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

  • The way to take this medicine: Oral
  • Store below 30 degrees Celsius
  • Lifetime is 5 Years.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Round white scored tablets marked with "bv" inside a hexagon

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.

Is this medicine subsidised?

This medicine is subsidised which may make it cheaper. To learn more about this subsidy, visit the Phamaceutical Benefits Scheme (PBS) website

Download leaflet

For side effects, taking other medicines and more

Download consumer medicine information leaflet (pdf)

Disclaimer

The information about this medicine comes from trusted sources.

  • Therapeutic Good's Administration (TGA)
  • Pharmaceutical Benefits Scheme (PBS)
  • GuildLink
  • DrugBank

healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

See also

Back to top back to top

Need more information?

These trusted information partners have more on this topic.

Top results

Female pattern hair loss (FPHL) - ACD

Female pattern hair loss (FPHL) is the term used to describe genetic hair thinning in females. This condition can affect women of any age but is more common after menopause. Around 40% of women show signs of FPHL by age 50.

Read more on Australasian College of Dermatologists website

Polycystic ovary syndrome - myDr.com.au

Polycystic ovary syndrome (PCOS) is a condition that affects females in their reproductive years. It may cause irregular periods, excess hair growth and cysts on the ovaries.

Read more on myDr website

Impotence causes - myDr.com.au

Find out the physical and psychological causes of impotence, also called erectile dysfunction or ED.

Read more on myDr website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback